Gibraltar Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,632
Closed -$769K 47
2023
Q4
$769K Sell
7,632
-3,141
-29% -$312K 0.33% 45
2023
Q3
$935K Sell
10,773
-15
-0.1% -$1.36K 0.41% 36
2023
Q2
$1.02M Sell
10,788
-17
-0.2% -$1.44K 0.45% 32
2023
Q1
$816K Buy
10,805
+956
+10% +$72.1K 0.38% 35
2022
Q4
$757K Sell
9,849
-98
-1% -$7.45K 0.36% 36
2022
Q3
$663K Buy
9,947
+1,591
+19% +$101K 0.34% 34
2022
Q2
$437K Buy
8,356
+54
+0.7% +$3.07K 0.21% 47
2022
Q1
$471K Buy
8,302
+2,339
+39% +$125K 0.2% 50
2021
Q4
$307K Buy
+5,963
New +$292K 0.14% 64

Other funds holding CAH

Gibraltar Capital Management's CAH Position: Q1 2024 in Review

Gibraltar Capital Management sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 7,632 shares — an estimated $769K sold.

Gibraltar Capital Management first reported a position in CAH in Q4 2021 and held it in 9 quarters. The position peaked at $1.02M in Q2 2023. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Gibraltar Capital Management reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
  • Gibraltar Capital Management sold 7,632 Cardinal Health shares in Q1 2024, an estimated $769K.
  • Gibraltar Capital Management first reported a position in Cardinal Health in Q4 2021 and held it in 9 quarters.
  • Gibraltar Capital Management's Cardinal Health position peaked at $1.02M in Q2 2023.
  • 1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Gibraltar Capital Management's 13F filing for Q1 2024, filed 7 May 2024.